3.0.0 4385 2022-12-31T05:07:24Z 2022-12-31T05:07:24Z House HR 2021-07-09 117 [Congressional Record Volume 167, Number 120 (Friday, July 9, 2021)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. HIGGINS of New York:H.R. 4385.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8[Page H3617]]]> hsed00 Education and the Workforce Committee House Standing Referred to 2021-07-09T14:04:05Z Cancer Drug Parity Act of 2021 117 3080 S 2021-10-27 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Identical bill CRS 2021-07-09 Referred to the House Committee on Education and Labor. IntroReferral H11100 2 House floor actions hsed00 Education and the Workforce Committee 2021-07-09 Introduced in House IntroReferral Intro-H 9 Library of Congress 2021-07-09 Introduced in House IntroReferral 1000 9 Library of Congress H001038 Rep. Higgins, Brian [D-NY-26] Brian Higgins D NY 26 N G000558 Rep. Guthrie, Brett [R-KY-2] Brett Guthrie R KY 2 2021-07-09 True M001163 Rep. Matsui, Doris O. [D-CA-6] Doris Matsui D CA O. 6 2021-07-09 True B001257 Rep. Bilirakis, Gus M. [R-FL-12] Gus Bilirakis R FL M. 12 2021-07-09 True M001206 Rep. Morelle, Joseph D. [D-NY-25] Joseph Morelle D NY D. 25 2021-07-09 True G000576 Rep. Grothman, Glenn [R-WI-6] Glenn Grothman R WI 6 2021-07-09 True C001055 Rep. Case, Ed [D-HI-1] Ed Case D HI 1 2021-09-10 False W000826 Rep. Wild, Susan [D-PA-7] Susan Wild D PA 7 2021-10-05 False M001208 Rep. McBath, Lucy [D-GA-6] Lucy McBath D GA 6 2021-10-20 False C001067 Rep. Clarke, Yvette D. [D-NY-9] Yvette Clarke D NY D. 9 2021-10-22 False P000613 Rep. Panetta, Jimmy [D-CA-20] Jimmy Panetta D CA 20 2021-10-28 False M000087 Rep. Maloney, Carolyn B. [D-NY-12] CAROLYN MALONEY D NY B. 12 2021-11-18 False B001278 Rep. Bonamici, Suzanne [D-OR-1] Suzanne Bonamici D OR 1 2021-11-18 False B000574 Rep. Blumenauer, Earl [D-OR-3] EARL BLUMENAUER D OR 3 2021-11-18 False S001201 Rep. Suozzi, Thomas R. [D-NY-3] Thomas Suozzi D NY R. 3 2021-11-18 False B001285 Rep. Brownley, Julia [D-CA-26] Julia Brownley D CA 26 2021-11-18 False T000483 Rep. Trone, David J. [D-MD-6] David Trone D MD J. 6 2021-12-07 False Y000033 Rep. Young, Don [R-AK-At Large] DON YOUNG R AK E. 0 2022-01-11 False C001078 Rep. Connolly, Gerald E. [D-VA-11] Gerald Connolly D VA E. 11 2022-01-11 False P000597 Rep. Pingree, Chellie [D-ME-1] Chellie Pingree D ME 1 2022-02-01 False Y000062 Rep. Yarmuth, John A. [D-KY-3] John Yarmuth D KY A. 3 2022-02-01 False F000466 Rep. Fitzpatrick, Brian K. [R-PA-1] Brian Fitzpatrick R PA K. 1 2022-02-01 False D000619 Rep. Davis, Rodney [R-IL-13] Rodney Davis R IL 13 2022-02-01 False A000376 Rep. Allred, Colin Z. [D-TX-32] Colin Allred D TX Z. 32 2022-02-08 False W000804 Rep. Wittman, Robert J. [R-VA-1] Robert Wittman R VA J. 1 2022-02-18 False B001295 Rep. Bost, Mike [R-IL-12] Mike Bost R IL 12 2022-07-13 False B001300 Rep. Barragan, Nanette Diaz [D-CA-44] Nanette Barragan D CA Diaz 44 2022-07-29 False B001248 Rep. Burgess, Michael C. [R-TX-26] Michael Burgess R TX C. 26 2022-09-21 False N000179 Rep. Napolitano, Grace F. [D-CA-32] GRACE NAPOLITANO D CA F. 32 2022-09-21 False C001061 Rep. Cleaver, Emanuel [D-MO-5] Emanuel Cleaver D MO 5 2022-09-21 False A000371 Rep. Aguilar, Pete [D-CA-31] Pete Aguilar D CA 31 2022-09-28 False C001066 Rep. Castor, Kathy [D-FL-14] Kathy Castor D FL 14 2022-09-28 False K000382 Rep. Kuster, Ann M. [D-NH-2] Ann Kuster D NH M. 2 2022-10-07 False M001203 Rep. Malinowski, Tom [D-NJ-7] Tom Malinowski D NJ 7 2022-10-28 False R000606 Rep. Raskin, Jamie [D-MD-8] Jamie Raskin D MD 8 2022-11-07 False E000296 Rep. Evans, Dwight [D-PA-3] Dwight Evans D PA 3 2022-11-14 False L000579 Rep. Lowenthal, Alan S. [D-CA-47] Alan Lowenthal D CA S. 47 2022-11-14 False Health Health 00 2021-07-09 Introduced in House 2022-02-10T18:17:45Z Cancer Drug Parity Act of 2021

This bill requires group health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with this requirement, plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.

]]> Cancer Drug Parity Act of 2021 Official Title as Introduced To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost sharing for oral anticancer drugs on terms no less favorable than the cost sharing provided for anticancer medications administered by a health care provider. Introduced in House IH Display Title Cancer Drug Parity Act of 2021 Short Title(s) as Introduced Cancer Drug Parity Act of 2021 Introduced in House IH Introduced in House 2021-07-09T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117hr4385ih/xml/BILLS-117hr4385ih.xml 2021-07-09 Referred to the House Committee on Education and Labor. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.